Since the expression levels of ATG5 and ATG7 are reduced in melanoma tissues and their expression levels correlated with the outcome of the patients, it is important to decipher the regulatory mechanisms responsible for the observed reduction. The gene discussed is ATG7; the disease is melanoma.